Cutler Group’s Viking Therapeutics VKTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q1
$28K Buy
+350
New +$28K 0.01% 486
2023
Q4
Sell
-2,495
Closed -$27K 2002
2023
Q3
$27K Sell
2,495
-2,211
-47% -$23.9K ﹤0.01% 820
2023
Q2
$76K Buy
4,706
+1,611
+52% +$26K 0.01% 528
2023
Q1
$51K Sell
3,095
-2,005
-39% -$33K 0.01% 629
2022
Q4
$47K Sell
5,100
-3,334
-40% -$30.7K ﹤0.01% 832
2022
Q3
$22K Hold
8,434
﹤0.01% 1171
2022
Q2
$24K Sell
8,434
-900
-10% -$2.56K ﹤0.01% 1134
2022
Q1
$28K Buy
+9,334
New +$28K ﹤0.01% 1249
2020
Q2
Sell
-19,300
Closed -$90K 2152
2020
Q1
$90K Buy
19,300
+14,300
+286% +$66.7K ﹤0.01% 621
2019
Q4
$40K Sell
5,000
-3,000
-38% -$24K ﹤0.01% 969
2019
Q3
$55K Hold
8,000
0.01% 783
2019
Q2
$66K Hold
8,000
0.01% 820
2019
Q1
$79K Sell
8,000
-4,200
-34% -$41.5K 0.01% 700
2018
Q4
$93K Sell
12,200
-10,730
-47% -$81.8K 0.01% 638
2018
Q3
$399K Buy
22,930
+9,060
+65% +$158K 0.03% 403
2018
Q2
$131K Buy
+13,870
New +$131K 0.01% 615